Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments

Recruiting

• Conditions: Depression; OCD; Anxiety Depression

• Registration Number: NCT06997549
• Lead Sponsor: Neuronetics

Brief Summary

The study involves multiple retrospective analyses to understand the utilization of mental health treatments provided at Greenbrook and their effectiveness

Detailed Description

this is a retrospective data analysis study that will utilize the already collected data as clinical care and will help understand the utilization and efficacy of various treatment options available for various mental heath conditions.

Study Timeline

• Status Verified: 2025-05
• Study Start: 2025-05-15
• Study First Submitted: 2025-05-21
• Study First Submitted QC: 2025-05-21
• Last Update Submitted: 2025-05-21
• Study First Posted: 2025-05-30
• Last Update Posted: 2025-05-30
• Primary Completion: 2035-12
• Study Completion: 2035-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 12000

Inclusion Criteria

• Male or female reported in database and not an invalid entry
• Age reported and not an invalid entry
• Treatment date in 2011 or later.

Exclusion Criteria

• Incomplete information on treatment parameters

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
change in clinical outcome scores from baseline to post treatment	8 weeks	real-world efficacy of NeuroStar TMS as compared to Esketamine in reducing patients' symptoms, reduction in clinical assessment score like PHQ-9

Trial Locations

Locations (1)

Neuronetics; 🇺🇸 Malvern, Pennsylvania, United States